Active FDA enforcement action
Warning Letter issued 2025-09-22. Status: Active. View on FDA.gov →
We're providing this information based on regulatory filings Vial reviewed as of 2026-08-21. Regulatory status can change, and actions may be resolved or closed out. Confirm current status with the issuing agency: FDA.gov →
ReviveRX
TX · Serves 45 states
Is this your company? Claim this profile.
ReviveRX is a compounding pharmacy available in 45 states. The FDA issued a warning letter involving ReviveRX on September 22, 2025, with no close-out letter found resolving it. Pricing was not publicly listed, so total cost should be confirmed before signing up.
Known forIn-person & telehealth
Why this score?
The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.
| 85-100 | High Confidence |
| 70-84 | Well Documented |
| 50-69 | Limited Confidence |
| 0-49 | Flagged |
ReviveRX scores 38, in the Flagged band. The score moves when the public record changes. For ReviveRX, the item most likely to move it: Pricing.
Payment never changes a score.
7 of 9 checks complete. The remaining checks have not been run yet. Missing checks reduce how complete the profile is. They are not a finding by themselves.
What we found on ReviveRX
We reviewed FDA enforcement records, OIG exclusions, DEA registration, HIPAA breach records, NPI registration, PCAB accreditation, and FDA 503B registration.
The FDA issued a warning letter involving ReviveRX on September 22, 2025. We have not found a close-out letter resolving it as of our last check (August 21, 2026); read the details below before going further. The company serves 45 states. We could not independently verify a third-party certification or accreditation as of August 2026.
Why this score: 7 of 9 checks complete. Each links to the public source it was verified against.
A check we haven’t completed yet is not a mark against this provider. It just means we’re still sourcing that record. The score reflects what we’ve confirmed so far, and updates as more checks come in.
Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed August 10, 2026.
Our take
Vial EditorialBased on the records and public materials we reviewed.
The FDA issued a warning letter to ReviveRX on September 22, 2025. We have not found a close-out letter resolving it. Before using this compounding pharmacy, ask what changed after the letter and confirm current status with FDA.
Questions we’d want answered
Worth asking before you choose
Ask these before you sign up.
- 1What changed after the FDA warning letter?
- 2Has FDA issued a close-out letter?
- 3Are you operating as a 503A pharmacy or a 503B outsourcing facility?
- 4Which states are you licensed to ship to?
- 5Can you provide current state pharmacy license details?
See all 5 questionsShow fewer
Screenshot these or show your doctor: they’re the same questions Vial would ask.
Compare record details
Empower Pharmacy holds LegitScript certification; ReviveRX does not.
Empower Pharmacy is PCAB-accredited; ReviveRX is not.
| ReviveRX | Empower Pharmacy | |
|---|---|---|
| Federal actions | On file | On file |
| Vial Score | 38/100 | 38/100 |
| LegitScript certified | No | Yes |
| PCAB accredited | No | Yes |
| States served | 45 states | Nationwide (50 states) |
What Vial measures, and what we don’t
We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.
Other compounding pharmacy providers in Vial
Other Compounding Pharmacy in Vial’s directory. Open a profile, or compare side by side.
See 2 more alternativesShow fewer
Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.
Find your providerMore compounding pharmacy providers
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.